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Abstract: Two stability indicating UV-spectrophotometric methods were developed and validated for the
determination of repaglinide with its degradation products. Assay of repaglinide in 0.1M NaOH and 0.1M HCl
were achieved at 216nm and 243nm respectively. The correlation was in the range of 1.0 – 25 µg mL-1 (r =
0.9999) for 0.1M NaOH and 2.0 – 40 µg mL-1 (r = 0.9999) for 0.1M HCl with molar absorptivity values of 2.02
× 104 L mol-1 cm-1 and Sandell sensitivity of 0.0224 µg cm-2 for 0.1M NaOHand 1.17 × 104 L mol-1 cm-1 and
Sandell sensitivity of 0.0386 µg cm-2 for 0.1M HCl. The detection limit and quantification limit are calculated to
be (0.13, 0.39 µg mL-1) and (0.18 and 0.54 µg mL-1) for 0.1M NaOH and 0.1M HCl respectively. The method
was validated for accuracy, precision, robustness, selectivity and applied for marketed formulations with less
than 2% relative error and standard deviation.
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INTRODUCTION AND EXPERIMENTAL
Stability testing and stress testing (forced
degradationstudies) are critical components of drug
development strategy1.Stress testing of the drug
substance can help identify the likely degradation
products, which can in turn help establish the
degradation pathways and the intrinsic stability of
the molecule and validate the stability indicating
power of the analytical procedures used2,3.The
studies help us to understand the mechanism of a
drug’sdecomposition, which further helps in
obtaining informationon physical and chemical
factors that result in instability4.These factors are
then controlled to stabilize the drugor drug
formulation, resulting in increased shelf-life
orimproved efficacy. According to International
Conference on Harmonization (ICH) guideline Q1A
(R2), the stability testing of drug substances should
be carried out under different stress conditions such
as hydrolysis, oxidation, photolysis and thermal
degradation to validate the stability-indicating
supremacy of analytical methods used for the
analysis of stability of drugs5.The standard
conditions for photo stability testing are described in
ICH guideline Q1B6. These tests allow accurate and
precise quantification of drugs and their degradation
products and interaction products.
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Repaglinide (RPG), chemically known as
(S)-(+)-2-ethoxy-4-[2-(3-methyl-1-[2-(piperidin-1-
yl)phenyl] butylamino)-2-oxoethyl]benzoic acid
(Fig.1) is a new carboxy methyl benzoic acid
derivative. It is a novel glucose regulator for the
treatment type-2 diabetes mellitus7.RPG is unusual
in that it has a rapid onset of action and a short
duration of action.  Repaglinide is extensively
metabolised by the cytochrome P450 (CYP) system
to inactive metabolites, and the main route of
excretion of repaglinide and its metabolites is via
bile into faeces8.The drug is official in USP9 which
describes liquid chromatographic method for its
quantification. From the literature survey, it is
revealed that very a few methods have been reported
for the determination of RPG in pure form and
dosage form; and include high performance liquid
chromatography10,11,12, reversed phase thin layer
chromatography13, charge transfer
spectroscopy14,and differential pulse
polarography15.However, the reported methodsare
not simple and require expensive equipments.
Besides, not many institutions can afford to procure
and maintain such instruments. The availability of a
simple and inexpensive UV spectrometry with
sensitivity and selectivity will be very useful for the










Figure 1. Chemical structure of RPG
Four UV spectrophotometric methods have
also been reported in the literature to determine RPG
in different solvent media. Firsttwo methods16
involve the measurement of absorbance of ethanolic
solution of repaglinide and metformin drug mixture
in direct measurement and Q-absorbance ratio. Both
methodsobey Beer’s law in the range 4 – 24 µg mL-
1RPG. Third method17 is a comparative study of
first-derivative spectrophotometry and HPLC which
have a linear range of 1 – 35 µg mL-1. Rajput et al 18
has determined RPG by measuring the absorbance at
281.2 nm in methanol with a linear range of 1-200µg
mL-1.
So far, to our knowledge, no stability
indicating assay has been reported for the
determination of RPG in the presence of its
degradants using the ICH approach of stress testing.
The proposed UV methods are very less expensive
and more accurate compared with the reported
methods.The focus of the study was to develop a
simple, rapid, accurate and precise stability
indicating UV-spectrophotometric method for the
determination of RPG in tablet dosage form.
Apparatus
Shimadzu Pharmaspec 1700 UV/Visible
spectrophotometer was used for absorbance
measurements.
 Materials
All chemicals used were of analytical
reagent grade. Doubly-distilled water was used to
prepare solutions wherever required. Hydrogen
peroxide (H2O2), hydrochloric acid and sodium
hydroxide were purchased from Merck (Mumbai,
India). Repaglinide pure compound (99.5%) was
kindly supplied by Torrent Pharmaceuticals Ltd,
Ahmedabad, India, as a gift. Eurepa-1 and Eurepa-2
tablets were purchased from local commercial
sources.
Reagents
Sodium hydroxide (5M) solution was
prepared by dissolving required amount of the
pellets in water. This solution was diluted to 0.1 M
and standardized and used as solvent to dissolve
drug. Hydrochloric acid (5M) was prepared by
appropriate dilution of concentrated acid (Sp. gr.
1.18)with water. A 5% solution of H2O2 was
prepared by diluting required volume of the
commercially available 30% reagent with water.
Standard drug solution
Standard stock solutionsof 200 µg mL-
1RPGwere prepared by dissolving 20 mg of pure
RPG in 0.1M NaOH and 0.1M HClseparately and
diluted to 100 mL with the respective solvent in
calibrated flasks. The solutions were further diluted
to obtain 40 and 20 µg mL-1RPG and used for assay.
General procedures
Preparation of calibration curve
Into a series of 10 mL calibration flasks,
aliquots of standard drug solution equivalent to 1.0 –
25 µg mL-1and 2.0 – 40 µg mL-1RPG were
accurately transferred and the volume were made up
to the mark with 0.1 M NaOHand 0.1M HCl,
respectively. The absorbance of each solution was
then measured at 216 nm and 243nm against0.1 M
NaOHand 0.1M HCl respectively.
Calibration curves were prepared by plotting
the absorbance versus concentration of drug. The
concentration of the unknown was read from the
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respective calibration curve or computed from the
regression equation derived using the Beer’s law
data.
Assay procedure for marketed tablets
Fifty Eurepa 2 tablets containing RPG (2
mg/tablet) and Hundred Eurepa 1 tablets containing
RPG (1mg/ml) were weighed and pulverized. The
amount of tablet powder containing 20 mg RPG was
transferred into a 100 mL volumetric flasks. The
content was shaken well separately with about 50
mL of 0.1 M NaOH or  0.1M HCl for 20 min and the
extract was diluted to the mark with the same
solvent. It was filtered using Whatman No 42 filter
paper. First 10 mL portion of the filtrate was
discarded and a subsequent portion was diluted to
get a working concentration of 20 µg mL-1 and 40
µg mL-1  respectively and subjected to analysis
following the general procedure described earlier.
Forced degradation studies
Two 200 µg mL-1RPG stock standard
solutions were prepared in 0.1 M NaOH and 0.1M
HCl separately. Five milliliters each of this solution
were accurately transferred to separate 50 mL
volumetric flasks. Five milliliters each of water, 5 M
HCl, 5 M NaOH or 5% H2O2 were added to the
flasks separately and the flasks were heated for 2 h
on a water bath maintained at 80 C. Then the
solutions were cooled and neutralized by adding
base or acid, the volume in each flask was brought to
the mark with the respective diluents, and
absorbance measured at 216 nm and 243 nm
respectively. Solid state thermal degradation was
carried out by exposing pure drug to dry heat at 105
C for 4 h. For photolytic degradation studies, pure
drug in solid state was exposed to 1.2million lux
hours in a photostability chamber. The sample after
exposure to heat and light was used to prepare 20 µg
mL-1and 40 µg mL-1solutions in 0.1 M NaOH and
0.1M HCl respectively, and the absorbanceswere
measured.
Method validation
Linearity, limits of detection and quantification
Linearity was established by analyzing
standard solutions containing 1.0 – 25.0 µg mL-
1RPG for method A and 2-40 µg mL-1 RPG for
method B. The limit of detection (LOD) and limit of
quantification (LOQ) values were calculated from
the calibration curve as k SD/b where k = 3.3 for
LOD and 10 for LOQ, SD is the standard deviation
of the blank absorbance values and b is the slope of
the calibration curve.
Intra-day and inter-day accuracy and precision
The intra-day and inter-day precisions of the
proposed methods were determined by measuring
the absorbance seven times on the same day and on
five different days using three different
concentration of RPG (10, 15 and 20 µg mL-1in
0.1M NaOH and 20, 30 and 40 µg mL-1 in 0.1M
HCl). From the absorbance values obtained,
concentration was calculated, and the results were
expressed as percentage relative standard deviation
(RSD). The accuracy was evaluated as percentage
relative error (%RE) between the found and taken
concentrations.
Robustness and ruggedness
Robustness of the method was determined
by deliberately varying the wavelength of detection
at three levels (216±1 nm for 0.1M NaOH and
243±1 for 0.1M HCl).Triplicate analysis was carried
out for three different concentrations of RPG(10, 15
and 20 µg mL-1in0.1M NaOH and 20, 30 and 40 µg
mL-1in 0.1M HCl)and the %RSD values were
evaluated for each concentration. For robustness, a
triplicate analysis was performed by four different
analysts, using four different cuvettes for the same
concentrations of RPG. The concentration of RPG
found in each case was calculated. The inter-mediate
precision expressed as RSD was evaluated.
RESULTS AND DISCUSSION
Spectral characteristics
The RPG solutions in 0.1M NaOH and 0.1M
HCl prepared separatelywere scanned in the
wavelength range from 200 to 400 nm. Maximum
absorbance of RPG was obtained at 216nm for 0.1M
NaOH and 243nm for 0.1M HCl, and at this
wavelength both the solvents havesignificant
absorbance(fig 2a, 2b).Therefore, further
investigation for the analysis of RPG was carried out
at 216 and 243 nmanalytical wavelength (λmax)
against 0.1M NaOH and 0.1M HClrespectively as
blank.
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Figure 2a.UV absorption overlay spectra ofRPG in 0.1 MNaOH and B. 0.1 M NaOH as blank.
Figure 2b.UV absorption overlay spectra of: RPG in 0.1 MHCl and 0.1 M HCl as blank.
Method validation
Linearity
Calibration plot was linear over 1.0 –
25.0µg mL-1for 0.1M NaOH and 2-40 µg mL-1 for
0.1M HCl .The slope (b), intercept (a) and
correlation coefficient (r) valuesfor both solvents
were evaluated by using the method of least squares
and were found to be -0.0443, 0.0012 and 0.9999,
respectivelyfor method Aand 0.0254, 0.0053 and
0.9999 for method B. The uncertainties with the y-
axis (Sy), intercept (Sa) and slope (Sb) were also
calculated. These results are presented in Fig-3 and
Table 1.
A B
Figure 3.Linearity curve of: A.RPG in 0.1 MNaOH and B. 0.1 M HCl.
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Sensitivity, limits of detection and quantification
Optical characteristics such as Beer’s law
limits, molar absorptivity and Sandell sensitivity
values are calculated. The limits of detection (LOD)
and quantification (LOQ) are also calculated and all
these dataare also presented in Table 1.
Precision
The results of intra-day and inter-day
analysis of the sample are given in Table 2. As
evident, %RSD values of the data obtained were all
below 3% .The %RSD values indicated that the
proposed method is sufficiently precise.
Accuracy
As shown from the data presented in Table
2, the relative error between the taken and found
concentrations of RPG is <2% indicating that the
proposed method is very accurate for the assay of
RPG.
Robustness and ruggedness
The assay was repeated at different
wavelengths and the results as presented in the table
3, clearly indicate that the results were unaffected by
the change in wavelength of detection. The
insignificant differences in absorbance values
demonstrated the good robust nature of the proposed
method. Intermediate precision values (%RSD) were
in the range 0.13–2.86% indicating acceptable
ruggedness. These results are presented in Table 3.
Application to tablet analysis
Commercial RPG tablets were analyzed
using the developed methods and also by a reference
published method19.The method describes a HPLC
determination of RPG ammonium phosphate buffer
and methanol with pH 4 mobile phase.The results
obtained were compared statistically by the
Student’s t-test and the variance-ratio F-test20. The
calculated t- and F- values did not exceed the
tabulated values of 2.77 (t) and 6.39 (F) at the 95 %
confidence level and for four degrees of freedom
(Table 4), indicating closesimilarity between the
proposed methods and the reference method with
respect to accuracy and precision.
Recovery study
To further ascertain the accuracy and
reliability of the proposed method, recovery
experiments were performed via standard-addition
procedure. Pre-analyzed tablet powder was spiked
with pure RPG at three different levels and the total
was found by the proposed method. Each
determination was repeated three times. The percent
recovery of pure RPG added was within the
permissible limits indicating the absence of inactive
ingredients in the assay. These results are as
illustrated in Table 5.
Table 1.Sensitivity and regression parameters
Parameter Value (Method-A) Value (Method-B)
max, nm 216 243
Linear range, µg mL-1 1.0 – 25.0 2.0 – 40.0
Molar absorptivity(ε), L mol-1cm-1 2.02 × 104 1.17 × 104
Sandell sensitivity*, µg cm-2 0.0224 0.0386
Limit of detection (LOD), µg mL-1 0.13 0.18
Limit of quantification (LOQ), µg mL-1 0.39 0.54
Intercept (a) 0.0012 0.0053
Slope (b) 0.0443 0.0254
Sy 0.0520 0.0041
Sa 0.0228 0.0027
Sb 2.5 × 10-4 1.2 × 10-4
Regression coefficient (r) 0.9999 0.9999
*Limit of determination as the weight in µg per ml of solution, which corresponds to an absorbance of A = 0.001
measured in a cuvette of cross-sectional area 1 cm2 and l = 1 cm. **Y=a+bX, Where Y is the absorbance, X is
concentration in µg/ml, a is intercept and b is slope
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Table 2.Evaluation of intra-day and inter-day precision and accuracy
%RE.Percent relative error, %RSD.relative standard deviation


















































Table 4.Results of analysis of Eurepa-2 and Eurepa-1 tablets by the proposed method and statistical
comparison of the results with the reference method
Found*























*Mean value of 5 determinations.
Tabulated t-value at the 95 % confidence level and for four degrees of freedom is 2.77.Tabulated F-value at
the 95 % confidence level and for four degrees of freedom is 6.39.
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Table 5.Results of recovery experiment via standard-addition method
*Mean value of three determinations.




















hydrolysis 20.00 28.76 143.80±0.66 20.00 20.31 101.55±0.26
Alkaline
hydrolysis 20.00 20.06 100.30±0.82 20.00 15.06 75.30±0.83
Neutral
hydrolysis 20.00 20.16 100.80±0.76 20.00 20.85 104.25±0.47
Oxidative
degration 20.00 0.98 9.51±0.54 20.00 10.98 54.90±0.65
Thermal
degradation 20.00 20.16 100.80±0.68 20.00 20.63 103.1±0.78
Photo
degradation 20.00 20.65 103.25±0.51 20.00 20.16 100.80±0.53
*Mean value of 3 determinations
Stability indicating property
The stability indicating property of the drug
was studied by a forced degradation study. The RPG
was subjected to acid, neutral, base and hydrogen
peroxide induced degradation in solution state, and
photo and thermal degradation in solid state. The
study was performed by measuring the absorbance
of RPG solution only after subjecting to forced
degradation. From the response, the percentage
recovery of RPG was calculated in each case and is
presented in Table 6. The results revealed that, there
was almost no change in the absorbance of RPG
solution resulting from base, neutral,thermal
andphoto degradationfor RPG in 0.1M NaOH. It
degraded significantly when cooked with acid and
H2O2. Similarly, RPG doesn’t show any degradation
with acid, neutral, thermal and photo degradation in
0.1M HCl solution and showed significant
degradation with basic and H2O2mediums.The
absorption spectra was recorded for this degraded
RPG and there was almost completely diminished
signal was observed. This confirms that RPG is
susceptible to oxidative degradation.
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CONCLUSIONS
Two simple, sensitive and stability
indicating UV-spectrophotometric methods have
been developed and validated. Stress studies showed
that the drug in 0.1M NaOHundergoes extensive
degradation in oxidative and acidic conditions and
stable underneutral, photolytic, and thermal
conditions.Simultaneously the drug is stable with
neutral, thermal and photolitic0.1M HCl and
degrades significantly in alkaline and oxidative
conditions.These are the first ever reported stability
indicating UV method for the quantification of
repaglinide. The proposed method is highly sensitive
and rapid, and requires no organic solvents or any
additional reagents. Furtherthe method is free from
any tedious procedural or extraction steps. The
instrument employedis very easy to handle and no
expertise personnel is required. The proposed
method was successfully applied to the commercial
tablets containing RPG as active ingredient. This
study is a typical example of development of a
stability indicating assay, established following the
recommendations of ICH guidelines. The method
can be used to determine the purity of the drug
available from various sources and in stability
studies.
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